Filter
6249
Filtered Results: 6249
Text search:
Center
for
Disease
Control
and
Prevention,
World
Health
Organisation
Featured
Recommendations
644
New Publications
1630
Language
Document type
No document type
3354
Studies & Reports
1054
Guidelines
917
Manuals
353
Strategic & Response Plan
264
Fact sheets
108
Training Material
94
Situation Updates
57
Resource Platforms
17
Infographics
11
Brochures
9
Online Courses
6
Dashboards/Maps
2
App
2
Videos
1
Countries / Regions
Global
284
India
282
Sierra Leone
166
Kenya
165
Liberia
144
Western and Central Europe
140
Nigeria
129
Ethiopia
126
Uganda
111
Latin America and the Carribbean
110
South Africa
110
Tanzania
88
Africa
87
Zambia
87
Nepal
83
Rwanda
81
Malawi
77
Ghana
69
Namibia
67
Ukraine
66
Bangladesh
65
Congo, Democratic Republic of
61
Philippines
58
Eastern Europe
57
Syria
56
Myanmar / Burma
56
Russia
54
Guinea
53
South–East Asia Region
45
South Sudan
45
Mozambique
43
Haiti
42
Senegal
41
Asia
40
Zimbabwe
39
Middle East and North Africa
37
Lesotho
36
Brazil
36
Cambodia
34
West and Central Africa
34
Burkina Faso
29
Germany
29
Eastern Europe and Central Asia
29
East and Southern Africa
28
Yemen
27
Indonesia
24
Botswana
23
Madagascar
20
Colombia
19
Cameroon
18
Pakistan
18
Afghanistan
17
Mali
16
Thailand
15
Venezuela
15
Western Pacific Region
15
Eswatini/ Swaziland
15
Tajikistan
13
Central African Republic
13
Côte d’Ivoire / Ivory Coast
12
Angola
12
Paraguay
11
Moldova
11
Somalia
11
Benin
10
China
10
Albania
10
Vietnam
10
Sudan
10
North America
9
Argentina
9
Georgia
9
Togo
8
Laos
7
Niger
7
Peru
7
USA
7
Guinea-Bissau
7
Jordan
7
Lebanon
7
Sri Lanka
7
Iraq
7
Chile
6
Burundi
6
Chad
6
North Macedonia
5
Gambia
5
Kazakhstan
5
Armenia
5
Saudi Arabia
5
Papua New Guinea
5
Poland
5
Timor Leste/ East Timor
4
El Salvador
4
Turkey
4
Hungary
4
Turkmenistan
4
Japan
4
Spain
4
Romania
4
Honduras
4
Ecuador
4
Mexico
3
Iran
3
Canada
3
Kyrgyzstan
3
Congo-Brazzaville
3
Jamaica
3
France
3
Belarus
3
Southern Africa
3
Bolivia
3
Palestine
3
Libya
3
Bhutan
3
Estonia
2
Uzbekistan
2
Malaysia
2
Bulgaria
2
Mauritania
2
Dominican Republic
2
Mauritius
2
United Kingdom
2
Bosnia and Herzegovina
2
Egypt
2
Slovakia
2
Serbia
1
Singapore
1
Morocco
1
Mongolia
1
Qatar
1
Italy
1
Cape Verde
1
Lithuania
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Azerbaijan
1
Israel
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Greece
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2240
Clinical Guidelines
527
Public Health
412
Key Resources
324
Women & Child Health
267
Capacity Building
90
Pharmacy & Technologies
76
Annual Report MEDBOX
1
Toolboxes
COVID-19
616
HIV
512
TB
441
Mental Health
364
Ebola & Marburg
268
AMR
242
Rapid Response
238
NTDs
218
Planetary Health
178
Caregiver
157
NCDs
141
Conflict
116
Disability
102
Refugee
100
Malaria
95
Zika
85
Global Health Education
85
Pharmacy
82
Health Financing Toolbox
71
Natural Hazards
53
Cholera
53
Polio
45
Specific Hazards
29
2.0 Rapid Response
24
Social Ethics
10
South Sudan
2
Typhoon
1
This policy brief outlines core elements that Member States are encouraged to a) develop an integrated approach to respiratory pathogen pandemic preparedness planning and b) enhance national and sub-national functional capacities for preparedness. In addition, this policy brief highlights suggested ...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi...
Pandemics and outbreaks have differential impacts on women and men. From risk of exposure and biological susceptibility to infection to the social and economic implications, individuals’ experiences are likely to vary according to their biological and gender characteristics and...
This Strategic Response Plan for the measles emergency in the WHO European Region (SRP) articulates the overall status of measles resurgence in the WHO European Region and the priority actions needed to ensure an effective response to interrupt transmission, save lives and reverse the regional trend...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global...
Laboratory testing for the monkeypox virus
recommended
Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi...
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
The recommendations in this guideline are intended to inform the development of relevant national- and local-level health policies and clinical protocols. Therefore, the target audience includes national and local public health policy-makers, implementers and managers of maternal and child health pr...
Risk Communication and Community Engagement (RCCE) is an essential component of your health emergency preparedness and response action plan. This tool is designed to support risk communication, community engagement staff and responders working with national health authorities, and other partners to ...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
WHO’s Ambition and Action in Nutrition 2016-2025 is anchored in the six global targets for improving maternal, infant and young child nutrition and the global diet-related NCD targets.
In support of the 2030 Agenda for Sustainable Development, particularly SDG2 and SDG3, and in concert w...
In support of the 2030 Agenda for Sustainable Development, particularly SDG2 and SDG3, and in concert w...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
